doi: 10.3390/molecules27092941 207 KrossR
Methods Study Setting Launched in April 2015 in collaboration with the National Psoriasis Foundation, the CorEvitas Psoriasis Registry (ClinicalTrials.gov: NCT02707341) is an independent, prospective, multicenter, non-interventional study that enrolls adults ( 18 years of age) who have been diagnosed with psoriasis, are willing and able to provide written informed consent for participation, and started on or switched to an eligible psoriasis treatment (US Food and Drug Administration [FDA]-approved biologic and non-biologic systemic therapies) at enrollment or 12 months before enrollment [12]
supports glutathione-family depigmenting use but not specific to the commercial material. Reduced glutathione has mechanistic depigmenting rationale via tyrosinase inhibition, antioxidant activity, and shifting melanogenesis toward pheomelanin
As always, it is crucial to consult with your healthcare provider before introducing a new supplement, especially if you are navigating a complex condition like Long COVID or ME/CFS, to ensure it aligns safely with your overall treatment protocol
10.1016/j.semcdb.2017.05.023 91 MungrueI